Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 63 of 1714:
53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73
Gene Compound Assay Inh Ic50 Ki View
thromboxane A synthase 1 ROSIGLITAZONE Thromboxane Synthetase 88% 3.56uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) ROSIGLITAZONE Thromboxane Synthetase 88% 3.56uM NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) DOMPERIDONE Adrenergic alpha1D 88% 1.065uM .524uM View
sodium channel, voltage gated, type VIII, alpha PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type VII, alpha PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type IV, beta PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type IV, alpha PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type III, alpha PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type II, beta PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type II, alpha 2 PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type I, beta PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type I, alpha PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type IV, beta PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel associated protein 1 PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel associated protein 2 PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type III, beta PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type I, alpha PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type IX, alpha PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type VII, alpha PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
calcium channel, voltage-dependent, gamma subunit 7 CLOMIPHENE Calcium Channel Type L, Phenylalkylamine 86% .754uM .733uM View
calcium channel, voltage-dependent, gamma subunit 6 CLOMIPHENE Calcium Channel Type L, Phenylalkylamine 86% .754uM .733uM View
calcium channel, voltage-dependent, gamma subunit 5 CLOMIPHENE Calcium Channel Type L, Phenylalkylamine 86% .754uM .733uM View
calcium channel, voltage-dependent, gamma subunit 4 CLOMIPHENE Calcium Channel Type L, Phenylalkylamine 86% .754uM .733uM View
calcium channel, voltage-dependent, gamma subunit 3 CLOMIPHENE Calcium Channel Type L, Phenylalkylamine 86% .754uM .733uM View
calcium channel, voltage-dependent, gamma subunit 2 CLOMIPHENE Calcium Channel Type L, Phenylalkylamine 86% .754uM .733uM View
calcium channel, voltage-dependent, gamma subunit 1 CLOMIPHENE Calcium Channel Type L, Phenylalkylamine 86% .754uM .733uM View
calcium channel, voltage-dependent, beta 4 subunit CLOMIPHENE Calcium Channel Type L, Phenylalkylamine 86% .754uM .733uM View
calcium channel, voltage-dependent, beta 3 subunit CLOMIPHENE Calcium Channel Type L, Phenylalkylamine 86% .754uM .733uM View
calcium channel, voltage-dependent, beta 2 subunit CLOMIPHENE Calcium Channel Type L, Phenylalkylamine 86% .754uM .733uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit CLOMIPHENE Calcium Channel Type L, Phenylalkylamine 86% .754uM .733uM View
calcium channel, voltage-dependent, alpha 1F subunit CLOMIPHENE Calcium Channel Type L, Phenylalkylamine 86% .754uM .733uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit CLOMIPHENE Calcium Channel Type L, Phenylalkylamine 86% .754uM .733uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit CLOMIPHENE Calcium Channel Type L, Phenylalkylamine 86% .754uM .733uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit CLOMIPHENE Calcium Channel Type L, Phenylalkylamine 86% .754uM .733uM View
calcium channel, voltage-dependent, beta 1 subunit CLOMIPHENE Calcium Channel Type L, Phenylalkylamine 86% .754uM .733uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit CLOMIPHENE Calcium Channel Type L, Phenylalkylamine 86% .754uM .733uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit CLOMIPHENE Calcium Channel Type L, Phenylalkylamine 86% .754uM .733uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 CLOMIPHENE Calcium Channel Type L, Phenylalkylamine 86% .754uM .733uM View
5-hydroxytryptamine receptor 6 S-(-)-PROPRANOLOL Serotonin 5-HT6 86% .998uM .463uM View
aldo-keto reductase family 1, member B4 (aldose reductase) TROGLITAZONE Aldose Reductase 86% 2.038uM NoneNone View
aldo-keto reductase family 1, member B1 (aldose reductase) TROGLITAZONE Aldose Reductase 86% 2.038uM NoneNone View
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) TROGLITAZONE Aldose Reductase 86% 2.038uM NoneNone View
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) TROGLITAZONE Aldose Reductase 86% 2.038uM NoneNone View
sodium channel, voltage-gated, type IV, beta PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel associated protein 1 PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel associated protein 2 PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, voltage-gated, type III, beta PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, voltage-gated, type I, alpha PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, voltage-gated, type IX, alpha PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, voltage-gated, type VII, alpha PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
amiloride-sensitive cation channel 5, intestinal PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, voltage-gated, type III, beta PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, voltage-gated, type XI, alpha PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, voltage-gated, type I, beta PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, voltage-gated, type 10, alpha polypeptide PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, voltage-gated, type IV, alpha polypeptide PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, voltage-gated, type V, alpha polypeptide PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, voltage-gated, type II, beta PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, nonvoltage-gated 1 alpha PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, nonvoltage-gated 1 gamma PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, nonvoltage-gated 1 beta PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, voltage-gated, type XI, alpha PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, nonvoltage-gated 1, gamma PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, nonvoltage-gated 1, delta PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, nonvoltage-gated 1 alpha PROMETHAZINE Sodium Channel, Site 2 86% 2.37uM 2.162uM View
sodium channel, voltage-gated, type XI, alpha THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, nonvoltage-gated 1, gamma THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, nonvoltage-gated 1, delta THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
amiloride-sensitive cation channel 5, intestinal PUROMYCIN Sodium Channel, Site 2 12% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, nonvoltage-gated 1 alpha THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type X, alpha THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type IX, alpha THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage gated, type VIII, alpha THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type VII, alpha THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type IV, beta THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type IV, alpha THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type III, alpha THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type II, beta THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type II, alpha 2 THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type I, beta THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
sodium channel, voltage-gated, type I, alpha THIORIDAZINE Sodium Channel, Site 2 86% 2.056uM 1.876uM View
opioid receptor, sigma 1 LEVOBUNOLOL Sigma1 86% .773uM .325uM View
opioid receptor, sigma 1 VALETHAMATE BROMIDE Sigma1 86% .475uM .2uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 IMATINIB Serotonin Transporter 86% 1.402uM .745uM View
5-hydroxytryptamine receptor 6 THIORIDAZINE Serotonin 5-HT6 86% .071uM .033uM View
5-hydroxytryptamine (serotonin) receptor 2C DOMPERIDONE Serotonin 5-HT2C 86% 1.332uM .698uM View
cholinergic receptor, muscarinic 2 METHAPYRILENE Muscarinic M2 86% 1.665uM .592uM View
estrogen receptor 1 4-NONYLPHENOL Estrogen ERalpha 86% .377uM .108uM View
estrogen receptor 1 4-NONYLPHENOL Estrogen ERalpha 86% .377uM .108uM View
Cytochrom P450-2D6 monooxygenase ORPHENADRINE CYP450-2D6 Inhibition 86% .4uM NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) RAPAMYCIN CYP450-2C9 Inhibition 86% 2uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 RAPAMYCIN CYP450-2C9 Inhibition 86% 2uM NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) MOSAPRIDE CYP450-2C9 Inhibition 86% 1uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 MOSAPRIDE CYP450-2C9 Inhibition 86% 1uM NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) TENIDAP CYP450-2C9 Inhibition 86% .7uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 TENIDAP CYP450-2C9 Inhibition 86% .7uM NoneNone View
Sigma-2 Receptor BERBERINE CHLORIDE Sigma2 86% .095uM .059uM View
tachykinin receptor 2 DOCETAXEL Tachykinin NK2 86% 1.563uM .521uM View
cholinergic receptor, muscarinic 2 PROMAZINE Muscarinic M2 86% 1.089uM .387uM View
Sigma-2 Receptor TERCONAZOLE Sigma2 86% .317uM .195uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 VX-745 Dopamine Transporter 86% 8.098uM 6.434uM View
histamine receptor H 2 METERGOLINE Histamine H2 86% .975uM .959uM View
5-hydroxytryptamine (serotonin) receptor 1B PROCHLORPERAZINE Serotonin 5-HT1B 86% 2.651uM 1.205uM View
dopamine receptor D1A PERGOLIDE Dopamine D1 86% .679uM .339uM View
adrenergic receptor, alpha 1d (Non-specific probe) PERGOLIDE Adrenergic alpha1D 86% 1.513uM .744uM View
amiloride-sensitive cation channel 5, intestinal MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, voltage-gated, type III, beta MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, voltage-gated, type XI, alpha MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, voltage-gated, type I, beta MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, voltage-gated, type 10, alpha polypeptide MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, voltage-gated, type IV, alpha polypeptide MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, voltage-gated, type V, alpha polypeptide MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, voltage-gated, type II, beta MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, nonvoltage-gated 1 alpha MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, nonvoltage-gated 1 gamma MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, nonvoltage-gated 1 beta MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, voltage-gated, type XI, alpha MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
calcium channel, voltage-dependent, gamma subunit 3 TIRILAZAD Calcium Channel Type L, Benzothiazepine 89% 2.694uM 2.395uM View
calcium channel, voltage-dependent, gamma subunit 2 TIRILAZAD Calcium Channel Type L, Benzothiazepine 89% 2.694uM 2.395uM View
calcium channel, voltage-dependent, gamma subunit 1 TIRILAZAD Calcium Channel Type L, Benzothiazepine 89% 2.694uM 2.395uM View
calcium channel, voltage-dependent, beta 4 subunit TIRILAZAD Calcium Channel Type L, Benzothiazepine 89% 2.694uM 2.395uM View
calcium channel, voltage-dependent, beta 3 subunit TIRILAZAD Calcium Channel Type L, Benzothiazepine 89% 2.694uM 2.395uM View
calcium channel, voltage-dependent, beta 2 subunit TIRILAZAD Calcium Channel Type L, Benzothiazepine 89% 2.694uM 2.395uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit TIRILAZAD Calcium Channel Type L, Benzothiazepine 89% 2.694uM 2.395uM View
calcium channel, voltage-dependent, alpha 1F subunit TIRILAZAD Calcium Channel Type L, Benzothiazepine 89% 2.694uM 2.395uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit TIRILAZAD Calcium Channel Type L, Benzothiazepine 89% 2.694uM 2.395uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit TIRILAZAD Calcium Channel Type L, Benzothiazepine 89% 2.694uM 2.395uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit TIRILAZAD Calcium Channel Type L, Benzothiazepine 89% 2.694uM 2.395uM View
calcium channel, voltage-dependent, beta 1 subunit TIRILAZAD Calcium Channel Type L, Benzothiazepine 89% 2.694uM 2.395uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit TIRILAZAD Calcium Channel Type L, Benzothiazepine 89% 2.694uM 2.395uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit TIRILAZAD Calcium Channel Type L, Benzothiazepine 89% 2.694uM 2.395uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 TIRILAZAD Calcium Channel Type L, Benzothiazepine 89% 2.694uM 2.395uM View
calcium channel, voltage-dependent, gamma subunit 8 TIRILAZAD Calcium Channel Type L, Benzothiazepine 89% 2.694uM 2.395uM View
calcium channel, voltage-dependent, gamma subunit 7 TIRILAZAD Calcium Channel Type L, Benzothiazepine 89% 2.694uM 2.395uM View
calcium channel, voltage-dependent, gamma subunit 6 TIRILAZAD Calcium Channel Type L, Benzothiazepine 89% 2.694uM 2.395uM View
calcium channel, voltage-dependent, gamma subunit 5 TIRILAZAD Calcium Channel Type L, Benzothiazepine 89% 2.694uM 2.395uM View
calcium channel, voltage-dependent, gamma subunit 8 AMIODARONE Calcium Channel Type L, Benzothiazepine 89% .054uM .048uM View
calcium channel, voltage-dependent, gamma subunit 7 AMIODARONE Calcium Channel Type L, Benzothiazepine 89% .054uM .048uM View
calcium channel, voltage-dependent, gamma subunit 6 AMIODARONE Calcium Channel Type L, Benzothiazepine 89% .054uM .048uM View
calcium channel, voltage-dependent, gamma subunit 5 AMIODARONE Calcium Channel Type L, Benzothiazepine 89% .054uM .048uM View
calcium channel, voltage-dependent, gamma subunit 4 AMIODARONE Calcium Channel Type L, Benzothiazepine 89% .054uM .048uM View
calcium channel, voltage-dependent, gamma subunit 3 AMIODARONE Calcium Channel Type L, Benzothiazepine 89% .054uM .048uM View
calcium channel, voltage-dependent, gamma subunit 2 AMIODARONE Calcium Channel Type L, Benzothiazepine 89% .054uM .048uM View
calcium channel, voltage-dependent, gamma subunit 1 AMIODARONE Calcium Channel Type L, Benzothiazepine 89% .054uM .048uM View
calcium channel, voltage-dependent, beta 4 subunit AMIODARONE Calcium Channel Type L, Benzothiazepine 89% .054uM .048uM View
calcium channel, voltage-dependent, beta 3 subunit AMIODARONE Calcium Channel Type L, Benzothiazepine 89% .054uM .048uM View
calcium channel, voltage-dependent, beta 2 subunit AMIODARONE Calcium Channel Type L, Benzothiazepine 89% .054uM .048uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit AMIODARONE Calcium Channel Type L, Benzothiazepine 89% .054uM .048uM View
calcium channel, voltage-dependent, alpha 1F subunit AMIODARONE Calcium Channel Type L, Benzothiazepine 89% .054uM .048uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit AMIODARONE Calcium Channel Type L, Benzothiazepine 89% .054uM .048uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit AMIODARONE Calcium Channel Type L, Benzothiazepine 89% .054uM .048uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit AMIODARONE Calcium Channel Type L, Benzothiazepine 89% .054uM .048uM View
calcium channel, voltage-dependent, beta 1 subunit AMIODARONE Calcium Channel Type L, Benzothiazepine 89% .054uM .048uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit AMIODARONE Calcium Channel Type L, Benzothiazepine 89% .054uM .048uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit AMIODARONE Calcium Channel Type L, Benzothiazepine 89% .054uM .048uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 AMIODARONE Calcium Channel Type L, Benzothiazepine 89% .054uM .048uM View
adrenergic receptor, alpha 1a YOHIMBINE Adrenergic alpha1A 89% 1.235uM .5uM View
adrenergic receptor, alpha 1b YOHIMBINE Adrenergic alpha1B 89% 1.188uM .658uM View
adrenergic receptor, alpha 2a DIHYDROERGOTAMINE Imidazoline I2, Central 89% .002503uM .001669uM View
adrenergic receptor, alpha 2c (Non-specific probe) DIHYDROERGOTAMINE Imidazoline I2, Central 89% .002503uM .001669uM View
adenosine A2a receptor TAMOXIFEN Adenosine A2A 89% 7.099uM 3.985uM View
5-hydroxytryptamine (serotonin) receptor 2C TAMOXIFEN Serotonin 5-HT2C 89% .46uM .241uM View
5-hydroxytryptamine (serotonin) receptor 2C CISAPRIDE Serotonin 5-HT2C 89% .767uM .402uM View
adrenergic receptor, alpha 2b CISAPRIDE Adrenergic alpha2B 89% 1.148uM .524uM View
calcium channel, voltage-dependent, gamma subunit 6 ERGOTAMINE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 ERGOTAMINE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 ERGOTAMINE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 ERGOTAMINE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 ERGOTAMINE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 ERGOTAMINE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit ERGOTAMINE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit ERGOTAMINE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit ERGOTAMINE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit ERGOTAMINE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit ERGOTAMINE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit ERGOTAMINE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit ERGOTAMINE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit ERGOTAMINE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit ERGOTAMINE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit ERGOTAMINE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit ERGOTAMINE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 ERGOTAMINE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
opioid receptor, delta 1 NELFINAVIR Opiate delta 54% 66.149uM 23.319uM View
5-hydroxytryptamine receptor 6 SUMATRIPTAN Serotonin 5-HT6 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 SILDENAFIL Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 SILDENAFIL Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 SILDENAFIL Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 SILDENAFIL Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 SILDENAFIL Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 SILDENAFIL Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 SILDENAFIL Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 SILDENAFIL Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View